1. Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation
   Sung Eun Kim et al, 2012, Journal of Materials Science: Materials in Medicine CrossRef
2. Current World Literature
   , 2011, Current Opinion in Supportive & Palliative Care CrossRef
3. Targeting anti-cancer agents to bone using bisphosphonates
   Lianping Xing et al, 2020, Bone CrossRef
4. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells
   Y. Açil et al, 2012, Journal of Cranio-Maxillofacial Surgery CrossRef
5. Development of Bone Targeting Drugs
   Molly Stapleton et al, 2017, International Journal of Molecular Sciences CrossRef
6. Bisphosphonate‐Functionalized Imaging Agents, Anti‐Tumor Agents and Nanocarriers for Treatment of Bone Cancer
   Robin A. Nadar et al, 2017, Advanced Healthcare Materials CrossRef
7. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages
   Petra Henning et al, 2024, Investigational New Drugs CrossRef
8. The effects of functionalized titanium with alendronate and bone morphogenic protein-2 for improving osteoblast activity
   Sung Eun Kim et al, 2013, Tissue Engineering and Regenerative Medicine CrossRef
9. Osteoblast migration into type I collagen gel and differentiation to osteocyte-like cells within a self-produced mineralized matrix: A novel system for analyzing differentiation from osteoblast to osteocyte
   Kazuyoshi Uchihashi et al, 2013, Bone CrossRef
10. Research progress of bone-targeted drug delivery system on metastatic bone tumors
    Beibei Hu et al, 2022, Journal of Controlled Release CrossRef
11. Bisphosphonate conjugation for bone specific drug targeting
    Kristen B. Farrell et al, 2018, Bone Reports CrossRef
12. A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases
    Camilla Thellenberg-Karlsson et al, 2023, European Journal of Cancer CrossRef
13. Nanomaterials for bone metastasis
    Xinyan Hao et al, 2024, Journal of Controlled Release CrossRef
14. Synthesis and Biological Evaluation of New Bisphosphonate–Dextran Conjugates Targeting Breast Primary Tumor
    Evelyne Migianu-Griffoni et al, 2014, Bioconjugate Chemistry CrossRef
15. Nanomedicine for the Treatment of Advanced Prostate Cancer
    Sonia Vicente‐Ruiz et al, 2021, Advanced Therapeutics CrossRef
16. Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering
    Dmitri A Ossipov, 2015, Expert Opinion on Drug Delivery CrossRef
17. Application of accelerator mass spectrometry to macromolecules: preclinical pharmacokinetic studies on a polybisphosphonate
    Mehran Salehpour et al, 2011, Rapid Communications in Mass Spectrometry CrossRef
18. New Progress in Improving the Delivery Methods of Bisphosphonates in the Treatment of Bone Tumors
    Yu Zhong et al, 2021, Drug Design, Development and Therapy CrossRef
19. Cancer bone metastases and nanotechnology-based treatment strategies
    Zhaofeng Li et al, 2022, Expert Opinion on Drug Delivery CrossRef